Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Anesta's Actiq denied FDA approval

Nov. 17, 1997

No Comments

Anticonvulsants with reduced side effects from RCT

Nov. 17, 1997

No Comments

Brain GABA-A receptor ligands prepared at Neurogen

Nov. 17, 1997

No Comments

Aradigm tests inhalation form of morphine in volunteers

Nov. 14, 1997

No Comments

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Nov. 14, 1997

No Comments

Roche in-licenses promising antiparkinsonian agent

Nov. 14, 1997

No Comments

CCK/gastrin receptor ligands from James Black Foundation

Nov. 13, 1997

No Comments

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

No Comments

FDA review of Myotrophin continues after resubmission

Nov. 12, 1997

No Comments

New neuroprotectants disclosed by Nippon Shinyaku

Nov. 12, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Anesta's Actiq denied FDA approval

Anticonvulsants with reduced side effects from RCT

Brain GABA-A receptor ligands prepared at Neurogen

Aradigm tests inhalation form of morphine in volunteers

nNOS inhibitor from Astra effective in animal models of stroke, ALS

Roche in-licenses promising antiparkinsonian agent

CCK/gastrin receptor ligands from James Black Foundation

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

FDA review of Myotrophin continues after resubmission

New neuroprotectants disclosed by Nippon Shinyaku

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS